N (male/female) | 29 (28/1) |
---|---|
Age (years) | 55 ± 12 |
Height (m) | 1.68 ± 0.07 |
Weight (kg) | 95.1 ± 32.7 |
BMI (kg/m2) | 33.3 ± 10.6 |
Duration of diabetes (years) | 12 ± 6 |
FPG (mg/dl) | 164 ± 52 |
HbA1c (%) | 7.4 ± 1.4 |
eGFR (ml/min/1.73m2) | 75.1 ± 23.8 |
Hypertension (%) | 86.2 |
Dyslipidemia (%) | 72.4 |
CVD (%) | 27.6 |
Concomitant anti-diabetic medication | Â |
None (%) | 13.8 |
SU (%) | 55.2 |
Metformin (%) | 79.3 |
TZD (%) | 24.1 |
AGI (%) | 10.3 |
SGLT2 inhibitor (%) | 6.9 |